Literature DB >> 404366

Pseudomonas species bacteremia caused by contaminated normal human serum albumin.

A C Steere, J H Tenney, D C Mackel, M J Snyder, S Polakavetz, M E Dunne, R Dixon.   

Abstract

In May and June 1973, 11 patients on the surgical service at the University of Maryland Hospital had bacteremia caused by Pseudomonas species. Seven of the isolates recovered from blood cultures had the same antibiogram (sensitive only to chloramphenicol and tetracycline). Ten of the 11 patients were given 25% normal serum albumin (human) shortly before the onset of symptoms. In contrast, only two of seven patients with bacteremia due to Psuedomonas aeruginosa in May and June (P =0.013) and only nine of 20 patients located in surgical special care units during these months (P =0.014) were given this product. When cultured, the albumin in one of 54 previously unopened vials from the implicated lot yielded Pseudomonas cepacia sensitive only to chloramphenicol, tetracycline, and nalidixic acid. Subsequent investigation showed that five more patients in four other hospitals had symptoms of bacteremia shortly after the infusion of different lots of albumin from the same manufacturer, and in four cases P. cepacia was cultured from the suspect albumin. Since sterility testing by manufacturers may not detect low-frequency contamination, surveillance of nosocomial infections, investigation of unusual disease clusters, and prompt reporting of suspect reactions are essential in the control of such outbreaks.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404366     DOI: 10.1093/infdis/135.5.729

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak.

Authors:  D J Anderson; J S Kuhns; M L Vasil; D N Gerding; E N Janoff
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Comparison of the standard pour plate procedure and the ATP and Limulus amebocyte lysate procedures for the detection of microbial contamination in intravenous fluids.

Authors:  R L Anderson; A K Highsmith; B W Holland
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 3.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

4.  Growth of nosocomial pathogens in multiple-dose parenteral medication vials.

Authors:  A K Highsmith; G P Greenhood; J R Allen
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

5.  Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa.

Authors:  L Saiman; G Cacalano; A Prince
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Resistance plasmids in Pseudomonas cepacia 4G9.

Authors:  J A Williams; J P Yeggy; C C Field; A J Markovetz
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

Review 8.  Unusual nosocomial infections.

Authors:  H C Neu
Journal:  Dis Mon       Date:  1984-10       Impact factor: 3.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.